You are here

lesinurad

Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster

Endpoints

Mon, 08/6/18 - 09:53 am

AstraZeneca bags FDA OK on gout drug lesinurad as safety doubts linger

Fierce Biotech

Wed, 12/23/15 - 11:14 am

AstraZeneca’s Share Price Is Volatile, Depends on Lesinurad

Yahoo/Market Realist

Tue, 12/8/15 - 11:04 pm

AstraZeneca Presents Positive Update on Lesinurad Renal Data in Gout Patients

Yahoo

Mon, 11/9/15 - 09:57 am

FDA reviewers question safety of AstraZeneca's gout drug

Yahoo/Reuters

Wed, 10/21/15 - 11:35 am

AstraZeneca Announces Phase III Results for Lesinurad in Combination with Febuxostat in Tophaceous Gout Patients at European League Against Rheumatism Annual Congress (EULAR 2015)

Yahoo

Sun, 06/14/15 - 10:50 pm

tophaceous gout

AstraZeneca gets pipeline boost from good gout drug results

Yahoo/AP

Wed, 08/13/14 - 08:12 am

Demon Disease Targeted by AstraZeneca as Gout Rates Soar

Bloomberg

Fri, 02/14/14 - 12:58 pm

AstraZeneca gets some good news for its late-stage gout therapy

Fierce Biotech

Fri, 12/13/13 - 10:53 am

AstraZeneca’s

Ardea Agrees with FDA on Gout Candidate

Yahoo/Zacks

Sat, 09/10/11 - 09:58 am

Ardea agrees with FDA on gout drug studies

Yahoo/AP

Thu, 09/8/11 - 11:16 am

Ardea shares climb after release of study results

Yahoo/AP

Fri, 05/27/11 - 08:54 am